Qyuns Therapeutics Co., Ltd. Class H (HK:2509) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Qyuns Therapeutics Co., Ltd. has outlined the structure of its board of directors, highlighting the roles and functions of its executive, non-executive, and independent non-executive members. The board, led by Chairman Mr. Qiu Jiwan, is organized into four committees focusing on audit, remuneration, nomination, and strategy, aiming to enhance corporate governance. This announcement provides insight into the company’s leadership and strategic direction, which may interest investors tracking board dynamics and corporate management.
For further insights into HK:2509 stock, check out TipRanks’ Stock Analysis page.